Siegfried AG Announces Board of Directors Nominations

Siegfried AG, a prominent Contract Development and Manufacturing Organization in the pharmaceutical industry, has announced the nomination of Thomas Wozniewski and Karl Petersson to its Board of Directors. The announcement was made on February 5, 2026. Thomas Wozniewski, with extensive experience from Takeda Pharmaceuticals, brings a wealth of knowledge in manufacturing and supply management. His expertise in technological and digital transformation is notable. Karl Petersson, from Interogo Long-Term Equity, offers significant insights into capital markets and investments. Their appointments will be proposed at the upcoming Annual General Meeting on April 16, 2026. Current Chairman Andreas Casutt will not seek re-election, likely to be succeeded by Beat Walti, subject to confirmation.